DAXXIFY
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
72960-112 -
Package NDC
72960-112-01 -
Package NDC
72960-112-02 -
Application number
BLA761127 -
SPL ID
5f798b51-9d9b-1d18-e063-6394a90a49c8 -
SPL set ID
3aaa6e14-a3f7-4fb2-b9f9-d3a9c3ae1f74 -
UNII
E211KPY694 -
RxCUI
2612454 -
RxCUI
2612456
What the source publishes
- Labeler
- Revance Therapeutics, Inc.
- Active ingredients
- botulinum toxin type A
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Routes
- INTRAMUSCULAR
- Administrative status
- present-in-source-snapshot
- Marketing status
- BLA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "DAXXIFY",
"splId": "5f798b51-9d9b-1d18-e063-6394a90a49c8",
"labels": [
{
"setId": "3aaa6e14-a3f7-4fb2-b9f9-d3a9c3ae1f74",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3aaa6e14-a3f7-4fb2-b9f9-d3a9c3ae1f74",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3aaa6e14-a3f7-4fb2-b9f9-d3a9c3ae1f74"
}
],
"routes": [
"INTRAMUSCULAR"
],
"labeler": "Revance Therapeutics, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 VIAL, SINGLE-USE in 1 CARTON (72960-112-01) / 1.2 mL in 1 VIAL, SINGLE-USE",
"package_ndc": "72960-112-01",
"identifierStatus": "well-formed",
"marketing_start_date": "20220920"
},
{
"sample": true,
"description": "1 VIAL, SINGLE-USE in 1 CARTON (72960-112-02) / 1.2 mL in 1 VIAL, SINGLE-USE",
"package_ndc": "72960-112-02",
"identifierStatus": "well-formed",
"marketing_start_date": "20220920"
}
],
"productId": "72960-112_5f798b51-9d9b-1d18-e063-6394a90a49c8",
"useDomain": "unknown",
"dosageForm": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
"productNdc": "72960-112",
"deaSchedule": null,
"genericName": "botulinum toxin type A",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "BOTULINUM TOXIN TYPE A",
"strength": "100 U/1.2mL"
}
],
"applicationNumber": "BLA761127",
"marketingCategory": "BLA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20220920",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175771",
"N0000193962",
"N0000175731",
"N0000175770"
],
"upc": [
"0372960112018"
],
"unii": [
"E211KPY694"
],
"rxcui": [
"2612454",
"2612456"
],
"spl_set_id": [
"3aaa6e14-a3f7-4fb2-b9f9-d3a9c3ae1f74"
],
"pharm_class_pe": [
"Neuromuscular Blockade [PE]"
],
"pharm_class_epc": [
"Acetylcholine Release Inhibitor [EPC]",
"Neuromuscular Blocker [EPC]"
],
"pharm_class_moa": [
"Acetylcholine Release Inhibitors [MoA]"
],
"manufacturer_name": [
"Revance Therapeutics, Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:72960-112_5f798b51-9d9b-1d18-e063-6394a90a49c8"